Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.
Giampaolo Merlini(University of Pavia), Pietro Garini(University of Pavia), Marilyn E. Ferrari(University of Pavia), E Ascari(Institute for Chemical and Physical Processes), Eloisa Arbustini(Policlinico San Matteo Fondazione), Vittorio Perfetti(University of Pavia), M G Marinone(University of Pavia), Vittorio Bellotti(University of Pavia), Irene Zorzoli(University of Pavia), Nadia Amboldi(University of Pavia)
Cited by 205
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k